Your browser doesn't support javascript.
loading
French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
Amoura, Z; Bader-Meunier, B; Bal Dit Sollier, C; Belot, A; Benhamou, Y; Bezanahary, H; Cohen, F; Costedoat-Chalumeau, N; Darnige, L; Drouet, L; Elefant, E; Harroche, A; Lambert, M; Martin, T; Martin-Toutain, I; Mathian, A; Mekinian, A; Pineton De Chambrun, M; de Pontual, L; Wahl, D; Yelnik, C; Zuily, S.
Affiliation
  • Amoura Z; Department of Internal Medicine, Institut E3M, CIMI-Paris, Faculty of medicine, National Reference Centre of Systemic Lupus, antiphospholipid syndrome, and other autoimmune diseases, Sorbonne University, AP-HP, Pitié Salpêtrière, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: Zahir
  • Bader-Meunier B; Laboratory of Immunogenetics of Paediatric Autoimmune Diseases, Institute Imagine, University Paris Cité, Paris, France.
  • Bal Dit Sollier C; Thrombosis and atherosclerosis research unit, vessels and blood institute (IVS), anticoagulation clinic (CREATIF), Lariboisière hospital, AP-HP, 75010 Paris, France.
  • Belot A; Department of Pediatric Nephrology, Rheumatology, Dermatology, Reference Centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), hôpital femme mère enfant, CHU de Lyon, Bron, France.
  • Benhamou Y; National Reference Centre of MicroAngiopathies Thrombotic, Paris, France; Department of Internal Medicine, University Hospital of Rouen, Normandie University, Rouen, France.
  • Bezanahary H; Department of Internal Medicine and Clinical Immunology, centre hospitalier universitaire de Limoges, Limoges, France.
  • Cohen F; Department of Internal Medicine, Institut E3M, CIMI-Paris, Faculty of medicine, National Reference Centre of Systemic Lupus, antiphospholipid syndrome, and other autoimmune diseases, Sorbonne University, AP-HP, Pitié Salpêtrière, boulevard de l'Hôpital, 75013 Paris, France.
  • Costedoat-Chalumeau N; Department of Internal Medicine, Referral Centre for Rare Autoimmune and Systemic Diseases of Île-de-France, AP-HP, Cochin Hospital, Paris, France; Centre for Epidemiology and Statistics, Institut national de la santé et de la recherche médicale, French National Institute for Agricultural Research,
  • Darnige L; Biological Hematology Department, Assistance publique-Hôpitaux de Paris, hôpital européen Georges-Pompidou, Inserm, UMR-S1140, Innovative Therapies in Haemostasis, Paris, France.
  • Drouet L; Thrombosis and atherosclerosis research unit, vessels and blood institute (IVS), anticoagulation clinic (CREATIF), Lariboisière hospital, AP-HP, 75010 Paris, France.
  • Elefant E; Reference Center for Teratogenic Agents, hôpital Armand-Trousseau centre de référence sur les agents tératogènes, Île-de-France, Paris, France.
  • Harroche A; Department of Hematology, Haemophilia Treatment Centre, University Hospital Necker Enfants Malades, Paris, France.
  • Lambert M; Department of Internal Medicine and Clinical immunology, Reference Centre of Autoimmune Systemic Rare Diseases Of North And North-West of France (CeRAINO), U1167 RID-AGE, Lille University, Inserm, University hospital of Lille, 59000 Lille, France.
  • Martin T; Department of Internal Medicine and Clinical Immunology, Strasbourg University Hospital, Strasbourg, France.
  • Martin-Toutain I; Resource and Competence Centre for Haemorrhagic Diseases, Hospital Center of Versailles André-Mignot, Le Chesnay, France.
  • Mathian A; Department of Internal Medicine, Institut E3M, CIMI-Paris, Faculty of medicine, National Reference Centre of Systemic Lupus, antiphospholipid syndrome, and other autoimmune diseases, Sorbonne University, AP-HP, Pitié Salpêtrière, boulevard de l'Hôpital, 75013 Paris, France.
  • Mekinian A; Department of Internal Medicine and Inflammation-Immunopathology-Biotherapy (DMU i3), Saint-Antoine Hospital, Sorbonne University, AP-HP, 75012 Paris, France.
  • Pineton De Chambrun M; Department of Internal Medicine, Institut E3M, CIMI-Paris, Faculty of medicine, National Reference Centre of Systemic Lupus, antiphospholipid syndrome, and other autoimmune diseases, Sorbonne University, AP-HP, Pitié Salpêtrière, boulevard de l'Hôpital, 75013 Paris, France.
  • de Pontual L; Department of Paediatrics, Jean-Verdier Hospital, AP-HP, HUPSSD, 93140 Bondy, France.
  • Wahl D; Vascular Medicine Division and Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
  • Yelnik C; Department of Internal Medicine and Clinical immunology, Reference Centre of Autoimmune Systemic Rare Diseases Of North And North-West of France (CeRAINO), U1167 RID-AGE, Lille University, Inserm, University hospital of Lille, 59000 Lille, France.
  • Zuily S; Vascular Medicine Division and Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, Nancy, France.
Rev Med Interne ; 44(9): 495-520, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37735010
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Thrombosis / Antiphospholipid Syndrome / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Guideline Limits: Adult / Child / Female / Humans / Pregnancy Language: En Journal: Rev Med Interne Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Thrombosis / Antiphospholipid Syndrome / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Guideline Limits: Adult / Child / Female / Humans / Pregnancy Language: En Journal: Rev Med Interne Year: 2023 Document type: Article